Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




3D Ultrasound Shows Speech Effects After Tongue Surgery

By HospiMedica staff writers
Posted on 02 Mar 2005
New research regarding tongue shape and volume before and after surgery should help surgeons plan how best to reconstruct defects of the tongue resulting from cancer, according to scientists. More...


Surgeons at the University of Toronto (Canada) are the first investigators to use three-dimensional (3D) ultrasound to evaluate both normal and partially resected tongues during speech. By assessing the 3D topography of the tongue's surface as each of 10 normal speakers made a host of sounds, the researchers were able to describe the basic processes underlying the normal workings of a tongue. This ultrasound data became the baseline to which partially resected tongues were compared. The study, funded by the Canadian Institutes of Health Research, was published in the January-February 2005 issue of the journal Clinical Linguistics & Phonetics.

"We used the data from the normal speakers to model a prototypical ‘Joe Canadian' tongue,” reported Dr. Tim Bressmann, a professor in the department of speech-language pathology at the University of Toronto. "This is a first step toward assessing the biomechanical impact of different reconstructive techniques on tongue movement for speech. Now, we can work toward determining what the ideal method of reconstruction is for different lesion locations and extents, so that we can ensure optimum speech outcomes for every patient.”

The investigators are now gathering ultrasound findings from more tongue cancer patients to device a database for surgeons who perform partial tongue resection surgeries. "The survival rate in tongue cancer is 70 to 80%,” stated Dr. Bressmann. "Therefore, surgeons need to do a very good job because people will often live with their reconstructions for a long, long time.”




Related Links:
University of Toronto

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.